Hiroyuki Hagiyama
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.
Journal: Annals of the rheumatic diseases
Published: October 27, 2025
High glucocorticoid dependency and limited therapeutic response in Japanese patients with VEXAS syndrome: a multicentre retrospective study.
Journal: Modern rheumatology
Published: July 01, 2025
Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseases.
Journal: Modern rheumatology
Published: December 20, 2024
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
Journal: Rheumatology (Oxford, England)
Published: March 10, 2023
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.
Journal: Rheumatology advances in practice
Published: April 28, 2020
Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital.
Journal: Arthritis research & therapy
Published: May 15, 2019
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan.
Journal: Modern rheumatology
Published: November 17, 2016
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.
Journal: Arthritis research & therapy
Published: August 26, 2016
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
Journal: Annals of the rheumatic diseases
Published: May 27, 2016
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study.
Journal: The Journal of rheumatology
Published: December 05, 2014
Amicrobial pustulosis-like rash associated with systemic lupus erythematosus.
Journal: The Journal of dermatology
Published: March 12, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026